3175 results for «439»
3175 results
EuroPCR 2022 in words and images - What did we learn this year?
20 May 2022 – From EuroPCR 2022
Watch this video to get a brief look at the highlights of EuroPCR 2022 and learn about the:
- 30 years radial interview (Jean Fajadet)
- PCR's Got Talent winner interview
- Top 3 memories on coronary: ROBOTIC PCI, simulation-based learning on stent dislodgment and U-REDUCE STENT registry
- Top 3 publications EuroIntervention and...
Emerging indications for TAVI
17 May 2022 – From EuroPCR 2022
Streamlining transfemoral TAVI in patients with peripheral atherosclerosis
17 May 2022 – From EuroPCR 2022
TAVI durability: important considerations for patient lifetime management
18 May 2022 – From EuroPCR 2022
Managing acute coronary perforation: a simulation-based team approach
18 May 2022 – From EuroPCR 2022
IVUS and OCT: when, how, why?
18 May 2022 – From EuroPCR 2022
Streamlined TAVI with Tokyo Live @EuroPCR
19 May 2022 – From EuroPCR 2022
Watch the live case from Milan, Italy, of an 88-year-old female patient with hypertension who was admitted for dyspnoea with discovery of severe aortic stenosis to consider state-of-the-art TAVI.
EuroPCR 2022 Andreas Grüntzig Ethica Award
19 May 2022 – From EuroPCR 2022
This award is an opportunity to highlight and thank nurses and allied professionals from all around the world for their unwavering commitment and outstanding skills, and to honour those who have been especially recognised during the Covid-19 pandemic.
How should I treat ostial circumflex restenosis?
19 May 2022 – From EuroPCR 2022
Consider how to treat circumflex restenosis after a left main crossover stent and circumflex restenosis after left main PCI with 2 stents and try to learn from the two cases presented in this session: what are the ostial circumflex restenosis mechanisms, and the treatment options? What...
Secondary mitral regurgitation: when and how to treat
19 May 2022 – From EuroPCR 2022
Watch a 46-year-old patient from Toulouse presenting a congestive heart failure syndrome with a severe secondary mitral regurgitation being treated live!
Image-guided bifurcation stenting - In vitro beating heart simulation-based learning from Japan
18 May 2022 – From EuroPCR 2022
The focus of this EuroPCR 2022 session is on complex bifurcation intervention: learn a step-wise approach using imaging in a bifurcation stenting strategy, acknowledge the geographical differences in the way we approach these techniques, and experience the use of simulation-based learning on an in vitro beating...
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
